Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile

  • Thomas P. Monath
  • , Jeroen Kortekaas
  • , Douglas M. Watts
  • , Rebecca C. Christofferson
  • , Angelle Desiree LaBeaud
  • , Brian Gowen
  • , Clarence J. Peters
  • , Darci R. Smith
  • , Robert Swanepoel
  • , John C. Morrill
  • , Thomas G. Ksiazek
  • , Phillip R. Pittman
  • , Brian H. Bird
  • , George Bettinger

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine

Psychology